Polyphosphorolyzing Agents for Nucleic Acid Amplification Specificity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for nucleic acid polymerization and amplification using polyphosphorolysis reactions are limited by the need for improved polyphosphorylating agents to enhance deblocking efficiency and specificity, particularly in detecting rare alleles and minimal residual disease.

Innovation Solution

The use of specific polyphosphorolyzing agents, such as triphosphates and tetraphosphates, in conjunction with enzymes like DNA polymerase, to activate blocked oligonucleotides and facilitate efficient extension and amplification of nucleic acids, including rare alleles, through polyphosphorolysis reactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional polyphosphorolysis methods are used for nucleic acid amplification, then amplification can be performed, but deblocking efficiency and specificity are insufficient leading to non-specific peaks and primer dimer formation

Engineering Contradiction:
ImprovespecificityVSAvoiddeblocking efficiency
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent changes the chemical parameters of the polyphosphorolysis reaction by using alternative polyphosphorolyzing agents (triphosphate, tetraphosphate, pyrophosphate) instead of conventional reagents. This parameter change improves both the specificity of the deblocking reaction and reduces non-specific background signals, thereby resolving the contradiction between reliability and ease of manufacture.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces polyphosphorolyzing agents as intermediary substances that mediate the deblocking of dideoxynucleotide-terminated primers. These intermediaries enable efficient and specific removal of blocking groups, improving both the efficiency and specificity of the amplification process without requiring complex procedural changes.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If polyphosphorolysis reactions are used to amplify nucleic acids, then amplification of rare alleles is possible, but non-specific peaks and primer dimer formation occur reducing detection accuracy

Engineering Contradiction:
Improvedetection accuracyVSAvoidnon-specific peaks and primer dimer formation
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent converts the potentially harmful non-specific binding and primer dimer formation into beneficial specific amplification by using polyphosphorolyzing agents that preferentially act on correctly annealed primer-template complexes. This transforms the harmful non-specific background into a benefit where only specific targets are amplified, improving detection accuracy for rare alleles.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

By changing the chemical parameters of the reaction system to include specific polyphosphorolyzing agents (triphosphate, tetraphosphate, or pyrophosphate), the patent alters the reaction kinetics and specificity. This parameter change suppresses harmful non-specific peaks and primer dimers while enhancing specific signal detection, thereby improving measurement precision.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If dideoxynucleotide blocking is used to enable allele-specific amplification, then rare allele detection is facilitated, but deblocking efficiency needs improvement for optimal performance

Engineering Contradiction:
Improveamplification efficiencyVSAvoiddeblocking efficiency
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent uses polyphosphorolyzing agents as intermediaries to efficiently remove dideoxynucleotide blocking groups from primers. These intermediaries catalyze the deblocking reaction, improving amplification productivity by ensuring complete and efficient removal of blocking groups, which enables optimal primer extension and nucleic acid amplification.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent optimizes deblocking efficiency by changing the chemical parameters of the polyphosphorolysis reaction through the use of triphosphate, tetraphosphate, or pyrophosphate. This parameter optimization ensures complete deblocking of primers, thereby maximizing amplification productivity and overall reaction efficiency.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach improves the specificity and efficiency of nucleic acid amplification, reducing non-specific peaks and primer dimer formation, and enables effective detection of rare alleles and minimal residual disease markers.

Implementation Method 1

polymerization of nucleic acids using activation by polyphosphorolysis (APP) reactions

Methodology Applied
Scientific EffectPolyphosphorolysis: Hydrolysis

Data Source

PatentUS9476093B2Polymerization of nucleic acids using activation by polyphosphorolysis (APP) reactions
Publication Date: 2016.10.25 LIFE TECHNOLOGIES CORP
  • US9476093B2 patent drawing
  • US9476093B2 patent drawing
  • US9476093B2 patent drawing

AI summary

This disclosure relates to methods of performing activation by polyphosphorolysis (APP) reactions using at least one of the polyphosphorylating agents triphosphate, polyphosphate, imidodiphosphate, thiodiphosphate (or μ-monothiopyrophosphate), and related compounds.